Brooklyn-based CyberLogic, Inc. develops ultrasound technologies spanning the FDA-approved UltraScan 650 bone densitometer and the Wave series of computational modeling software. Its radiation-free UltraScan 650 measures bone mineral density at the 1/3 radius in under 10 seconds, while Wave2000, Wave2500 and Wave3000 simulate two- and three-dimensional viscoelastic wave propagation for engineering and research. The company’s work grows out of more than 30 years of ultrasound research, peer-reviewed studies and patented technologies.
U.S. FDA Approval for UltraScan 650
compliance_program